To be entered into the prize draw, you need to view three short webinars on feline chronic kidney disease (CKD) on the Boehringer Academy website – www.boehringer-academy.co.uk.
The online seminars, which each last for approximately 20-30 minutes, count towards CPD and are as follows:
Tuesday 20 June at 7.30pmThe role of IDEXX SDMA in early diagnosis of feline CKDLearn how you can detect feline CKD earlier and more reliably with the IDEXX SDMA blood testSusan Randell, Head of Internal Medicine at IDEXX Laboratories
Tuesday 4 July at 7.30pmThe importance of early diagnosis in feline CKDUnderstand the importance of early diagnosis in cases of CKD and the impact this can have on progression of the diseaseSarah Caney, RCVS Recognised Specialist in Feline Medicine
Tuesday 18 July at 7.30pmThe balanced approach to feline CKDDiscover more about the balanced approach to managing the progression of feline CKDSarah Caney, RCVS Recognised Specialist in Feline Medicine
The three-day ISFM congress takes place at Le Méridien Phuket Beach Resort from 7-9 November. The congress will explore the latest developments in feline medicine and keynote speakers, Carolyn O’Brien and Jessica Quimby, will cover a range of current and challenging feline medicine topics. Local speakers complement the varied programme, which aims to offer practical hints and tips for delegates to take back and use in clinic.
The prize includes flights, transfers and bed and breakfast accommodation for two people for three nights in Phuket, as well as two delegate tickets to the ISFM congress. The prize draw will take place w/c 14 August.
To enter, watch all three new Semintra webinars on the Boehringer Academy website: www.boehringer-academy.co.uk.
Of the remaining 47% of the 386 veterinary surgeons, nurses, rehabilitation professionals, practice managers, assistants and students who took part in the online survey, 29% expressed uncertainty about whether the profession is respected, and 18% said they do not feel part of a respected community.
Of those who do not feel part of a respected community, social media bashing and the accusation that you're only in it for the money emerged as repeated explanations.
However, remarks from those who said they DO feel respected included:
"People are always impressed when you say you work in veterinary."
"As a professional clients have a certain respect towards me and I feel like a valued member of the community. People always want to talk to the vet in social situations because we have such a fascinating profession."
"People recognise the hard work to reach the role as a vet and appreciate helping their four-legged family members greatly."
"Having built up longstanding relationships with clients over the years, I feel we have a great sense of belonging. We support local events and get lots of positive feedback on social media etc."
When asked whether their vocation in veterinary medicine was all that they thought it would be, 51% of respondents said yes. Of the others, the three most common reasons why their career had not met expectations were: "Low work-life balance", "Financial concerns" and "High demands from clients".
The three things respondents most aspired to were: "Healthy work-life balance" (81%), Making a difference to the lives of animals" (81%), and "Continue to develop my skills" (78%).
When asked what three things respondents would like to change about the profession, 48% said "Client expectations", 46% said "Recognition as a valued role in society" and 46% said "Financial package".
Founder of VET Festival, Professor Noel Fitzpatrick said: "Despite being part of a profession that feels the stresses and strains of failure, financial pressure, difficult relationships, self-confidence, and even fear on a day-to-day basis, it is heartening to see that collectively we still absolutely find a deep sense of fulfilment and pride in what we do.
"Despite the many challenges we face in our vocation, if there is one thing we can learn from these findings, it is that we are all in it together. We cannot be the best version of ourselves without recognising a common sense of purpose and a desire to support each other, in whatever guise as veterinary professionals.
"We give so much of ourselves in companion animal practice to looking after our patients and the families who love them, we sometimes need to remind ourselves of the need to look after ourselves too and most importantly to look after each other as colleagues and friends sharing the same journey, passion, challenges and responsibilities.
This message is integral to the ethos and interactive learning streams of VET Festival 2018."
Tim Harrison, managing director at White Cross Vets, said: "Our plan has been to open five new practices within a 12 month period and despite having a strong presence in West Yorkshire we didn’t have a practice in South Yorkshire. When we found out Dave wanted to move to Sheffield it made perfect sense for us to expand into the area and for him to lead the practice as clinic director.
"Dave is a hugely talented and compassionate professional and we certainly didn’t want to lose him. The Handsworth opening is the perfect fit for Dave who will lead a team of four. As the practice expands, we envisage that we will create a further 20 jobs over the next five years.”
White Cross says it has invested £250,000 in the practice, which is opening on the site of a former sausage factory which has recently been redeveloped at a cost of £1.1M.
Dave said: "I was so thrilled when Tim told me his plans for Sheffield. I love the area and my wife’s family have grown up there, I have been wanting to set up a long term family home for a while, and the fact that I have been able to move my young family to South Yorkshire, and still work for White Cross Vets, makes me really happy."
Vetoquinol is launching Cimalgex, a new NSAID for dogs this month.
Cimalgex (cimicoxib) is a new second generation COX-2 inhibitor which can be used for the treatment of pain and inflammation due to osteoarthritis and the management of peri-operative pain associated with orthopaedic and soft tissue surgery, for which it can be given two hours before surgery and continued for 3-7 days post surgery.
Vetoquinol says that an important consideration in treating dogs with osteoarthritis, many of which are geriatric, is that there are no contraindications to using Cimalgex in patients with mild to moderate renal impairment.
According to the company, field trials showed that over 90 per cent of per owners and vets identified that animals experienced excellent analgesia post operatively*.
Available in a chewable, splitable tablet, Cimalgex can be given with or without food.
Vetoquinol says that the excellent tolerability, efficacy profile and ease of use of Cimalgex means that veterinary patients could benefit from pain relief in situations where clinicians are worried about the risks versus the benefits of prescribing a NSAID for pain management.
Further information about assessing pain and decision making when it comes to prescribing NSAIDs, will be presented in a free webinar on 19th October at 8.30pm. To register go to www.thewebinarvet.com/vetoquinol and enter code CIM1.
Reference*E. Grandemange: Field evaluation of the efficacy and the safety of cimicoxib in the relief of peri-operative pain in dogs; 2008, study number n°3008C2F1
The Prince's Trust 'creates life-changing opportunities' for those aged 11-30 and Nick has long-held a passion for making a difference to young lives. He has set up three charities for young people: with learning disabilities; who want to campaign to change the world; and who want to break down the barriers to enjoying nature and the outdoors.
Nick has led the RCVS since September 2012. During his tenure, developments at the College include a new Royal Charter, major governance reform, improved regulation of veterinary nurses, the instigation of Vet Futures, the introduction of the alternative dispute resolution service, significant evolution within the Practice Standards Scheme, the refocusing of RCVS Trust into RCVS Knowledge, the launch of Mind Matters, and the recognition of the College as a Great Place to Work.
Nick said: "It has been a great privilege to be CEO of the College and to work with such amazing staff, such a progressive Council and such a decent and caring profession. It is no surprise to me that vets and vet nurses are among the most trusted professionals in this country, and in my view this is due to their professionalism and to the excellence of the Royal College in maintaining and advancing standards. I hope I have played my part in helping the College and the profession navigate through a period of great change and preparation for significant change to come.
"At The Prince’s Trust I will be focused on the next generation, helping to give young people the confidence and purpose they need to make a success of their lives and the world around them. I know from my own personal experiences of school, and the various charities with which I have been involved, how many young people are not given the best chance in life. I cannot think of a better mission to take on."
RCVS President Chris Tufnell said: "I feel very fortunate to have worked closely with Nick over his five years with the RCVS; he has made a tremendous contribution to the College and our professions. With his energy and drive, he has infused the College with a culture of openness, engagement and dedication and has inspired the team through some impressive achievements.
"Nick’s leadership will enable vets and veterinary nurses to fulfil their potential and it's fitting that he's moving on to a role which benefits the lives of others. Meanwhile, there's a considerable amount of important work being done by the RCVS and I am confident that we have a strong team at Belgravia House to manage this until the new CEO is in post."
The RCVS says its Operational Board will be reflecting on Nick’s successes and the future needs of the College, before developing a specification for the new CEO and a recruitment process over the coming weeks.
The researchers say that ultimately the study should help with the development of guidelines to help all riders assess if they are the right weight for the horse or pony they intend to ride, to enhance both equine welfare and rider comfort and enjoyment.1
Dr Sue Dyson, Head of Clinical Orthopaedics at the Animal Health Trust’s Centre for Equine Studies, Newmarket, who led the study said: "While all the horses finished the study moving as well as when they started, the results showed a substantial temporary effect of rider weight as a proportion of horse weight.
"The results do not mean that heavy riders should not ride but suggest that if they do they should ride a horse of appropriate size and fitness, with a saddle that is correctly fitted for both horse and rider.
"We must remember that this is a pilot study: further work is required to determine if horse fitness, adaptation to heavier weights and more ideal saddle fit will increase the weight an individual horse can carry. This should help us further in our quest to develop guidelines for optimum rider: horse bodyweight ratios."
As the average weight and height of humans continues to increase there is growing debate about relative rider-horse sizes, with riding school horses epitomising the variety of weights of rider that a single horse may be exposed to.
Numerous inter-related aspects are involved with the horse and rider combination including the age of the horse, its fitness and muscle development, the length of its back and the presence or absence of lameness. The rider’s skill, fitness, balance and coordination are important factors, as is the fit of the saddle to both the horse and rider. The type, speed and duration of work and the terrain over which the horse is ridden must also be considered.2
To date little research has been conducted on the effects of rider weight on equine welfare and performance. To address the shortfall World Horse Welfare, the Saddle Research Trust, the British Equestrian Federation and a number of other organisations helped to fund a pilot study last summer, the results of which have now been analysed.
The influence of rider to horse bodyweight ratios on equine gait and behaviour: a pilot study1 assessed gait and behavioural responses in six horses ridden by four riders of similar ability but different sizes. The riders were all weighed in their riding kit and were subsequently categorised as being light, moderate, heavy and very heavy. Their body mass index (BMI) was also calculated.
Each rider rode each horse in its usual tack and performed a set pattern of exercises comprising mainly trot and canter. Gait, horse behaviour, forces under the saddle, the response to palpation of the back, alterations in back dimensions in response to exercise, heart and respiratory rates, salivary cortisol levels and blink rate were assessed for each combination.
The riding tests for the heavy and very heavy riders were all abandoned, predominantly because of temporary horse lameness. This was likely to have been induced by bodyweight rather than BMI, given that the heavy and moderate riders had similar BMIs, both being classified as overweight, yet only one of the moderate rider’s tests had to be abandoned. An ethogram, developed by Dr Dyson specifically to assess behavioural markers which may reflect pain in ridden horses3, was applied. The scores which may reflect pain were significantly higher in the horses when ridden by the heavy and very heavy riders.
The study also raised the issue of rider height and saddle fit. The owner of one of the test horses had a similar bodyweight: horse bodyweight ratio to the heavy rider and was of similar weight, but significantly different in height (157.0 and 185.5 cm, respectively). This large difference in height has major potential implications for saddle fit for the rider and consequently the rider’s position and weight distribution. The taller rider sat on the back of the cantle, overloading the back of the saddle and making it more difficult to ride in balance, with the heel being in front of a vertical line between the shoulder and ‘hip’.
Roly Owers, Chief Executive of World Horse Welfare, said: "These pilot results are certainly not surprising but are very significant in adding vital evidence to inform an appropriate rider: horse weight ratio. It is common sense that rider weight impacts equine welfare however many might not fully understand or recognise this. What is desperately needed is basic guidance to help riders identify a horse or pony that is right for them and this research is a vital step in that direction.”
The study was generously supported by World Horse Welfare, the Saddle Research Trust, Frank Dyson, British Equestrian Federation, British Horse Society, Pony Club, Polocross, The Showing Council, The Showing Register, The Society of Master Saddlers, Riding for the Disabled, British Eventing, British Dressage, the British Horse Foundation, the Worshipful Company of Saddlers and Endurance GB.
References
Amongst the speakers were Catherine Oxtoby MRCVS, Risk Manager at the Veterinary Defence Society, and Dr Huw Stacey, director of clinical services at Vets4Pets.
Dr Stacey explained how Vets4Pets and Companion Care practices are embracing a culture of sharing information when things don’t go according to plan in practice.
He said: "We all face challenges in the workplace, and this event focused on how different professions can share ideas and good practice and how they find solutions to any challenges.
"The culture of aviation and maritime is one of minimising risk and putting safety first, and it is fascinating to compare their approach to that found in medicine and veterinary.
"One common theme we discussed was the wellbeing of both professionals and patients or clients, with tiredness being at the top of the list of things that can negatively affect wellbeing and performance.
"Both aviation and maritime recognised that long shifts, particularly overnight, needed to be reduced in order to improve the outcome for everyone.
"In veterinary and human medicine, tiredness and long shifts are often worn as a badge of honour and being tired at work was something that should be admired, rather than addressed.
"But, tired vets are effectively neglecting themselves and their own wellbeing, which in turn leads to pets not receiving the best level of care in practice.
"This is something we’re taking seriously at Vets4Pets and Companion Care, and we’re currently looking at ways to decrease the risk of overworked and tired vets and vet nurses."
Another area of discussion was around the reporting of near misses and when things don’t go right, and how veterinary professionals need to identify and share the learnings from these events, not only within their practice, but with the wider profession too.
He said: "We need to continually emphasise the concept of a ‘just’ culture, to ensure our colleagues feel confident about reporting incidents open and honestly."
"It is not in the interests of the professional, the patient or the client to bottle things up, and at Vets4Pets and Companion Care we’re encouraging all of our practices to adopt the VDS VetSafe system, which provides a mechanism for sharing incident reports across the profession, enabling us all to learn from them to the benefit of our patients."
The Easy to Give Awards are given to pharmaceutical companies that have made it easier to give medication to cats:
Dechra for Felimazole coated tablets for cats
Zoetis for Stronghold Plus spot-on solution for cats
Zoetis for VibraVet Paste
Bayer for Seresto flea and tick collar for cats
The Cat Friendly Awards recognise products which have made a difference to cat wellbeing:
ProtectaPet for cat fencing solutions
Coastline Global for Kit4Cat Cat Urine Sample Collection Sand
Sure Petcare for its SureFlap Microchip Pet Door Connect with Hub
The Distance Education Awards recognise the best students on the International Society of Feline Medicine’s Vet Nursing courses
Sarah Hayward and Rachael Hodgeson for best results achieved in the Certificate in Feline Nursing
Margaret Hodgeson for the best result received in the Diploma in Feline Nursing
In addition, International Cat Care made a special award in 2018 for products and ideas which have made major contributions to the ability to help cats in the field of Trap, Neuter, Return (TNR). The Innovation in Humane Cat Population Management Award was given to MDC Exports for its traps, restrainers and transfer baskets.
Lastly, the winner of the 2018 iCatCare Photography Competition winner, awarded to the overall winner of the charity’s ‘Kittenhood’ photo competition, was Lindsey Chadwick.
Photo: Liz Rawlings and Craig Sankey from Dechra with their Easy to Give award for Felimazole
The double-blind placebo-controlled study will examine whether the pheromone collar can help reduce the severity or development of certain potentially problematic behaviours in puppies and it is open to puppies less than 12 weeks of age.
Puppies will have to wear a collar until they are six months of age and their owners will be asked to complete a check sheet relating to their puppy’s behaviour every month. Each month a new collar will be sent direct to their home.
To encourage enrolment, the University of Lincoln is offering veterinary professionals a £10 voucher for every successful sign up to the trial.
Owners who complete all questionnaires will receive a pack of canine health and welfare goodies from Ceva Animal Health. The pack will include Adaptil Junior, Adaptil Transport and Logic Oral Hygiene Gel.
Owners will also be entered into a draw to win an iPad.
A marketing pack is available to raise awareness of the study and includes a waiting room poster, owner leaflets and a social media post for Twitter, Facebook or Instagram.
For further information, email the University of Lincoln at puppydevelopment@lincoln.ac.uk.
Stefano qualified in Parma, Italy and has a Master’s in Clinical Oncology. He has worked in a number of referral practices, managing and treating small animal oncological cases. He also has an interesting history of working with animals across the globe: he has a Master’s in Tropical Veterinary Medicine and worked with the United Nations in Somalia, Malaysia and Guyana in wildlife management.
Founder, CEO and Clinical Director of The Ralph, Shailen Jasani said: "We had always planned to include an oncology service here at The Ralph though not quite this soon after opening. However, over the last eight months, this has been one area of veterinary medicine where we have not been able to serve our patients, their carers or our referral community. This did not sit well with us. Serendipity being what it is, our path crossed with Stefano's and we were able to extend our services."
For more information, visit www.theralph.vet
For the study1, 158 cows presented with active DD (M1, M2 or M4.1 stage) and were randomly allocated to either the control or the treatment group.
All cows were treated with a topical application of oxytetracycline spray.
The treatment group also received an intramuscular injection of Ketofen 10% solution for injection (ketoprofen 3mg/kg).
Cows were mobility scored just before they were treated and then again one week later.
The results indicated that animals in the control group were 2.57 times more likely to be lame at the second evaluation compared to those that received Ketofen, however cows that were lame in the control group prior to treatment and did not receive Ketofen were over 20 times more likely to remain lame a week post-treatment compared to cows that did receive Ketofen.
The same study all showed a milk yield benefit overall; treated cows produced 2.98 kg more milk than control cows (T = 45.35 C = 42.37, p<0.01).
When only lame fresh cows were considered, there was a 10.49kg increase in milk yield (T = 58.38 C = 47.89 p<0.05).
Nick Bell MA, VetMB, PhD, PGCert Vet Ed, FHEA, DipECAWBM(AWSEL), MRCVS, veterinary surgeon and director of Herd Health Consultancy, said: “We’ve widely recognised the importance of NSAIDs for treating claw lesions, which are primarily inflammatory conditions, but this study is the first real insight into how important NSAIDs are for any lesion, including digital dermatitis, particularly if the cow is showing signs of lameness.
"This research provides a clear welfare justification for giving NSAIDs to dairy cows with active digital dermatitis lesions, with significant milk yield benefits.”
Katherine Timms BVetMed(Hons) MRCVS, ruminant veterinary advisor at Ceva Animal Health said: “While it is recognised that some stages of digital dermatitis are painful, there has been little research to determine the value of including analgesia in the treatment of the condition.
“This study suggests that the use of Ketofen in the treatment of pain and lameness associated with active digital dermatitis lesions may be beneficial for animal welfare as it is associated with an improvement in mobility scores.”
Reference
The AWF funds research, supports veterinary education, provides pet care advice and encourages debate on animal welfare issues.
AWF trustees are responsible for facilitating the achievement of the charity’s mission, providing strategic direction and safeguarding AWF’s brand and reputation.
The charity is now inviting applications from veterinary professionals with current or recent experience in production animal practice.
Trustees are expected to attend at least two meetings a year during their three-year term, as well as AWF’s annual flagship event in Westminster, the AWF Discussion Forum. They are also encouraged to engage with one or more of AWF’s Sub Committees focussing on particular areas of the charity’s activity, such as grant making and public education.
AWF Trustee Nicola Martin said: "Being an AWF Trustee gives you a fantastic opportunity to work on a wide range of welfare issues facing a variety of species rather than just those in your area of expertise. I enjoy discussing and debating issues, sharing my views and understanding those of others, as well as having the chance to shape the future of this great charity."
Simon Doherty, BVA Junior Vice President and AWF Trustee, said: "As a vet with a long-standing interest in research that provides an evidence base for animal welfare policy decisions, my involvement with AWF has given me the opportunity to promote research not only within my specialist fields of livestock and aquaculture but also learn more about welfare research in the companion animal sector.
"AWF does excellent work in engaging members of the public and the profession with crucial animal welfare topics, so I’d urge my colleagues to apply as Trustees to help direct the charity’s work in the future."
The deadline for AWF Trustee applications is 9am on 20 August 2018. For more information, visit: https://www.animalwelfarefoundation.org.uk/about-us/become-a-trustee/
The company says the initiative, which is targeted at veterinary professionals and farmers, will be supported by an extensive social media, advertising and PR campaign.
The social media campaign will take the form of social media content, newsletter articles and images for veterinary practices to use on their social media channels and will include information on the cost of dairy cow lameness and tips to manage lameness.
Rose Jackson BVSc DBR CertVBM MRCVS is the farm clinical director at Scarsdale Vets which has already trialled the new materials. She said: “The ‘Wave Goodbye to Pain’ social media content has ensured that we are able to post eye-catching and thought-provoking content to continue to engage with our clients and raise awareness of the ‘triple works’ approach to lameness in cows, which includes using a NSAID such as Ketofen, alongside a trim and block for a more complete recovery from lameness than trimming alone.”
The ‘Wave Goodbye to Pain’ campaign was launched following a study by Nottingham University which revealed that NSAIDs have a synergistic effect when given alongside effective hoof trimming and blocking to treat lameness1.
The study looked at claw horn disease of the hind foot and found that trimming alone resulted in a 69% rate of return to mobility without lameness in 35 days. Adding a block into an effective trimming protocol raised the success rate to 72%; trimming and administering a NSAID raised it to 76%. Interestingly, using all three techniques together - trimming, applying a block and administering an NSAID - resulted in 85% of cases being successfully resolved (Mobility score or 0 or 1).
Gemma Robinson BVM BVS MRCVS, ruminant veterinary adviser at Ceva Animal Health, said: “The study highlights that effective and prompt pain relief with NSAIDs can quickly help restore animals back to full productivity. Attitudes on the use of pain relief have changed significantly over the last 10 years and dairy farmers can have a positive influence by ensuring they recognise the value of NSAIDs and prioritise their use on-farm. It is important that vets discuss NSAIDs with their clients, both to manage illness and for routine procedures, and our ‘Wave Goodbye to Pain’ campaign will help encourage farmers to think about their current pain management plan, take action and seek help from their vet.
“Some concerns have been raised that the issues associated with antimicrobial resistance and antibiotic administration are causing farmers to avoid the use of all injectable treatments. We need to be clear that NSAIDs are anti-inflammatories, not antibiotics, and it is important they are used for pain management, fever and the clinical signs associated with many common conditions. With zero milk-withhold NSAIDs available - there really is no reason to hesitate when it comes to administering pain relief in otherwise healthy cattle.”
For more information on the ‘Wave Goodbye to Pain’ campaign visit the website designed for farmers (www.wavegoodbyetopain.co.uk), contact your local Ceva territory manager or call 01494 781510.
To request a copy of the ‘Wave Goodbye to Pain’ social media pack (including pre-developed posts and images which you can send out to your own clients), speak to your Ceva territory manager or email: cevauk@ceva.com with your name, practice name and address details.
Merial Animal Health has launched Veloxa, a palatable broad spectrum dewormer for dogs, effective against roundworm, hookworm, whipworm and tapeworm.
Merial says Veloxa uses a proprietary technology which coats the bitter active ingredients in the beef-flavoured chewable tablets. In the company's palatability tests it achieved 97% acceptance.
Veloxa tablets are scored for accurate dosing and come in two sizes:
Christine Male, Product Manager of Veloxa said: "Merial has a strong heritage in anti-parasitics and understands how difficult it can be for pet owners to administer worming tablets, so we are extremely pleased to be able to offer Veloxa as part of the Merial anti-parasitics range."
According to statistics from the RCVS, almost 40% of veterinary surgeons that have registered in the UK since 2005 qualified from veterinary schools elsewhere in the EU.
Of course, it's not just in general practice that veterinary surgeons and veterinary nurses from other EU member states make such an important contribution. They work across all areas of veterinary science, including the fields of animal health and welfare, animal disease surveillance, scientific research and education, wildlife conservation, and public health and food safety.
Figures from the Veterinary Public Health Association (VPHA) estimate that over 90% of vets in meat hygiene services are non-British EU citizens.
To highlight the impact of Brexit on the veterinary profession, the BVA has written to the Secretary of State, Liz Truss MP, and to Ministers in Scotland, Wales and Northern Ireland, requesting an early statement to the effect that non-British EU vets and vet nurses who are currently living, studying or working in the UK will continue to be able to do so in future.
BVA is also seeking reassurance for UK veterinary professionals working and studying in other EU member states.
BVA President Sean Wensley said: "It is not yet possible to comment on the reality of ‘Brexit’ since much will depend on forthcoming negotiations and the decisions that will be taken by the Government regarding, for example, whether or not to maintain existing EU legislation and rules. However, we recognise that these unanswered questions are having a profound impact on many of our members – particularly members who are non-British EU citizens, or have family members who are, and members who work alongside colleagues from other European Member States."
In the letters, Mr Wensley wrote: "I am sure there are many significant issues that your Department needs to consider [and] given the profound personal impact that the uncertainty caused by the referendum outcome is having on some of our members, we wanted to contact you at the earliest opportunity. In the forthcoming negotiations about the future relationship between the UK and the EU, we strongly urge you to make the case for all EU citizens and EU-qualified veterinary surgeons and nurses to have ongoing rights to live, work and study in the UK."
In the letter to the Northern Ireland (NI) Minister of Agriculture, Environment and Rural Affairs Michelle McIlveen MLA, the BVA President and BVA NI Branch President Seamus O’Kane highlighted NI’s land border with EU member state the Republic of Ireland and called for the maintenance of the Common Travel Area to facilitate movement in an all-island context for both work and study purposes.
VPHA President Lewis Grant said: "Due to the particular focus on public health in many European veterinary degree courses, EU vets make an enormous contribution to both public health and animal health and welfare in the UK - often behind closed doors, monitoring and protecting public health in Approved Premises as well as welfare at slaughter to ensure slaughterhouses meet the standards that are required by law and expected by the public. Without their input and expertise, it would be difficult to ensure that Statutory requirements within the food industry are complied with."
Reporter Andy Davies spoke to Charlotte Debbaut MRCVS, a veterinary surgeon from Belgium working at the Tindale Veterinary Practice in Gloucestershire, where there are 13 vets with eight different nationalities. He also interviewed Matthew Pugh MRCVS and Ovidiu Oltean MRCVS from Belmont Veterinary Centre, a mixed practice in Hereford which employs five foreign nationals out of a team of 13 veterinary surgeons.
Finally, he talked to John Blackwell MRCVS at Brownlow Veterinary Group in Shropshire, where Brexit had already caused a Croatian member of his team to refuse a permanent position and return to Ireland.
Congratulations to the RCVS and BVA press offices, who will have been hard at work behind the scenes.
See: https://www.channel4.com/news/brexit-affecting-vet-recruitment
Sheldon is managing director of RVC Veterinary Practices Ltd and principal at Acorn House Veterinary Hospital in Bedford. He has been with the practice for 14 years. A graduate of Cambridge University he has a particular interest and a GP Certificate in ophthalmology. He has been a member of the BSAVA Board for the past five years and a volunteer since graduation.
Sheldon says that during his Presidency he will focus on shaping Congress 2022 into the ultimate veterinary get-together as the country begins its release from the challenges and constraints of the pandemic. He said: "With more than 3,300 registrations, the turnout for and particularly the engagement with BSAVA Virtual Congress 2021 was phenomenal, given the challenges the profession is currently facing as a result of the pandemic.
“We intend to build on this for BSAVA Congress 2022, by deploying a cleverly blended format to retain the high degree of accessibility and flexibility that delegates have so enjoyed this year. We will be releasing further details on BSAVA Congress 2022 in the early summer.”
Sheldon says he will also be focusing on BSAVA’s support for the small animal veterinary community as it emerges from the pandemic.
"The profession has shown incredible resilience and dynamism in responding to the changing demands of our patients but we need to be careful that this is not at the expense of our own wellbeing. BSAVA’s community support, practical education and science resources and leadership are all there to support the profession as it pivots to a new way of working.”
BSAVA Virtual Congress 2021 content is accessible for another 6 weeks. Visit https://www.bsavaevents.com/bsavacongress2021/en/page/home.
Ceva Animal Health has announced the launch of Cardalis for the treatment of canine heart failure caused by degenerative valvular heart disease.
Cardalis contains what the company says is a unique combination of benazepril and spironolactone in one tablet which provides "dual blockade" of the RAAS system.
Benazepril reduces the production of angiotensin II, which causes narrowing of the blood vessels, while spironolactone blocks the harmful effects of aldosterone, which include cardiovascular remodelling and fibrosis.
Cardalis tablets are small, beef flavoured and designed to be administered once a day with food. Each pot contains 30 tablets and there are three sizes available. Ceva says it should be given as part of standard heart failure therapy as soon as clinical signs, such as exercise intolerance, coughing or dyspnoea, appear.
Fraser Broadfoot, small animal product manager at Ceva Animal Health, said: "Through our clinical studies, it has been found that dogs receiving benazepril and spironolactone (compared with benazepril alone) have a better quality of life and, at any one time, are three times less likely to die from heart failure.
"We have also assessed 101 dogs in a field study that were prescribed Cardalis for three months, followed by separate benazepril and spironolactone tablets for two weeks. In the study, 97 per cent of dog owners found Cardalis easier to administer than the two separate tablets and 89 per cent of vets found Cardalis easier to prescribe."
For further information about Cardalis, or to receive marketing materials for the product (which include a waiting room poster and client information booklets), visit www.ceva.com.uk, or contact the practice support team on 01494 781510.
The new bill - Animal Welfare (Sentencing and Recognition of Sentience) - would increase the maximum prison sentence for animal cruelty tenfold, from six months to five years, in England and Wales.
The draft bill also sets out that the government "must have regard to the welfare needs of animals as sentient beings in formulating and implementing government policy".
Subject to consultation on the draft bill, the government says it will legislate to deliver both aims.
In fact, the draft bill goes further than Article 13 as it applies to all areas of government policy, rather than specified areas of policy. If passed, the law would apply to the whole of the UK.
Environment Secretary Michael Gove said: "Animals are sentient beings who feel pain and suffering, so we are writing that principle into law and ensuring that we protect their welfare. Our plans will also increase sentences for those who commit the most heinous acts of animal cruelty to five years in jail. We are a nation of animal lovers so we will make Brexit work not just for citizens but for the animals we love and cherish too."
BVA President John Fishwick said: "Vets have been clear in our calls that the duty on the state to have due regard for animal welfare - as captured in Article 13 of the EU Lisbon Treaty - must be enshrined in UK law. This Bill captures the substantive obligation that Article 13 currently puts on the national government to consider animal welfare, as well as explicitly recognising animals as sentient beings."
"Today’s draft Bill lays out in black and white the Government making good on its promises, to ensure the UK remains a global leader in animal welfare post-Brexit."
Tuloxxin contains Tulathromycin and Krka says it is based on the same formulation as the market leader.
In cattle Tuloxxin is administered using a single subcutaneous injection; in sheep Tuloxxin is licensed for use in the treatment of foot rot associated with Dichelobacter nodosus and also in pigs for swine respiratory disease (SRD) administered via a single intra-muscular injection. Krka says it is fast-acting, and that the one dose formulation supports compliance and so reduces stress to herds and flocks.
Charlotte Read, Key Account Manager – Farm, at Krka, said: "Whenever Krka launches a generic product, we aim to add some extra value to it. Tuloxxin is a good example. It is based on a tried and trusted active and delivers efficacy; with formulation and delivery method technology at exceptional value. We hope its launch will support vets in their appropriate choice of antibiotic for specific cases. In so doing, they will be protecting their clients’ cattle and profitability while also playing their part in reducing antimicrobial use.”
Tuloxxin is available now from all wholesalers.
40% of the dry food is a 'flour' made from Hermetia illucens larvae reared in a new, £18 million facility in Holland. Other ingredients include British grown oats, potato and a number of other botanicals.
Insects require only a small fraction of the resources to farm than other forms of protein, such as chicken or beef. The manufacturer says that compared to beef, its grubs need just 2% of the land and 4% of the water to produce each kilogram of protein, which means they generate 96% less greenhouse emissions. And they don't need any antibiotics or growth hormones.
The manufacturer also says insects are easier to digest than chicken, making Yora ideal for pets with sensitive stomachs.
TV vet Rory Cowlam MRCVS is throwing his weight behind the new dog food. He said: "Yora provides a healthy, high protein alternative to conventional kibble. It’s hypoallergenic, and free from antibiotics and growth hormones. Pets love the taste – plus it’s great for the planet.
"As a keen conservationist and dog lover, I am incredibly excited by the enormous potential for this dog food to reduce our pets’ collective carbon pawprint."
Tom Neish, founder of Yora, said: "Animals and humans have been eating insects since the dawn of time and we believe Yora is the future of pet food. We have trialled 29 recipes to find the perfect combination of great tasting ingredients and are very proud of the end result.
"Yora enables dog owners to take the lead in giving their dog a nutritious, tasty food whilst having a positive impact on the environment."
Yora is available to buy online or from Pets Corner stores, priced at £13.99 for a 1.5kg bag.
If you're interested in stocking Yora at your practice, contact Hollie Smith, Marketing and Operations Manager on 01293 265618, or email hollie@yorapetfoods.com
Now, I'm off to buy a bag for my dog. I figure it should be easier to persuade Daisy that an insect-based diet is necessary to save the planet, than my wife.
MSD Animal Health has launched Bovilis IBR Marker Inac, an inactivated marker vaccine for use in the control of Infectious Bovine Rhinotracheitis (IBR).
The company says the new product complements Bovilis IBR Marker Live and creates a range now offering greater simplicity and additional flexibility for veterinary surgeons seeking optimum control protocols for their clients' herds.
MSD Animal Health ruminant veterinary adviser Drew McGurren MRCVS said: "Farmer compliance is an important part of any successful vaccination programme. With this extended Bovilis IBR Marker programme, farmers can now start IBR vaccination of their cattle from three months of age with a single shot primary course of Bovilis IBR Marker Live, easily followed by boosters every six months using a single dose of either Bovilis IBR Marker Live or Bovilis IBR Marker Inac. Both primary course and boosters can be administered by the same intramuscular route.
"Alternatively, Bovilis IBR Marker Inac can be administered to cattle from three months of age as a primary course of two injections four weeks apart. The programme then follows a six monthly single dose booster regime.
"The availability of Bovilis IBR Marker Inac provides a simple control option in defined farm situations, not least where an alternative to the live vaccine is preferred or required. Overall, we see this development adding convenience, ease of use and flexibility for veterinary surgeons as they work with their clients to control a significant disease threat in dairy and beef cattle in the UK."
Bovilis IBR Marker Inac is a prescription-only medicine (POM-V). The product is available from wholesalers now in 10 and 50 dose vials. For further information, contact the MSD Animal Health Veterinary Support Group on 01908 685685.
The platform, which is available to Premier Pet Care Plan and Animal Healthcare clinics, is designed to help practices increase the number of sign-ups to health care plans.
Romain Regnier (pictured right), PVA’s Business Analyst Manager said: "The current situation has accelerated the need for a digital transformation.
"To help vet practices reach this goal, we have created a highly customisable digital sign-up solution, which mirrors the practice’s branding and can be used in communications to the customer, giving you more possibilities to promote your plans."
With a digital platform, practices can now encourage owners to sign up whilst waiting - socially distanced - outside, or from home.
Debbie Saunders, PVA’s Customer Experience Manager said: "It’s a two-pronged solution; reducing the impact that limited interactions with clients is having on health care plan signs ups and allowing practices to advertise their plans more efficiently.
We are encouraging practices to post about their new digital sign-up links on social media, so pet owners complete their forms anywhere. It will make a big difference to veterinary staff, reducing the amount of administrative pressure from plans but also allowing a direct call to action from advertising."
Each practice will be given unique urls, tiny urls and QR codes which link to the platform, alongside additional marketing materials. The marketing packs contain some customisable content, including social media assets, website banners and printable posters, all free to use to promote the new sign-up platform.
The digital sign-up platforms come with personalisation options, allowing practices to customise their webpage with their own logos, text, and branding, with the help of their PVA trainer.
If you are a Premier Pet Care Plan or Animal Healthcare clinic and are interested in integrating a digital sign-up form into your practice, contact your PVA trainer or call 0117 370 0300 .
Enrobactin contains enrofloxacin but is uniquely available in 10ml bottles for convenient dispensing in practice.
Enrobactin can be used to treat digestive, respiratory tract and skin and wound infections and features a distinctive caramel aroma.
Madeline Haynes, Product Manager, said: "Offering practices solutions which are efficacious but also easy to use is a key focus at Virbac, particularly given the importance in practice of using antibiotics responsibly and accurately across all species. Enrobactin is a good example of this and we are pleased to launch it."
The first, carried out by Nanna Luthersson and colleagues and published online in the Journal of Equine Veterinary Science in March, evaluated the laminitis risk factors in a group of Danish horses and ponies.1 It confirmed that Cold-blooded type animals <149cm, such as certain native ponies, as well as those being kept on high quality pasture were at an increased risk of developing laminitis for the first time. It also highlighted the important role that a change in grass intake, in terms of both type and amount, may play at any time of the year not only the spring as commonly thought.
The second study, funded in part by the PetPlan Charitable Trust, British Veterinary Association Animal Welfare Foundation Norman Hayward Fund and the Laminitis Trust, was undertaken in conjunction with Nicola Menzies-Gow (Royal Veterinary College) and published online in the Equine Veterinary Journal (EVJ) in August. The study evaluated the risk factors for the development of laminitis prior to the occurrence of the disease.2 It identified that low concentrations of the adipose tissue derived hormone adiponectin, together with high serum insulin concentrations (at rest and as part of a diagnostic test for PPID) may predict an increased risk of future pasture-associated laminitis.
It is hoped that future studies will be able to generate more robust cut off values, which will more accurately predict future laminitis development in an individual animal.
The RVC in collaboration with Waltham is now taking this forward through a study in which these markers are measured regularly, in conjunction with a detailed management assessment, in a group of ponies with no known history of laminitis at the start.
Clare Barfoot RNutr and the research and development manager at Spillers said: "The Danish study gives us important practical facts about the susceptibility of cold-blooded types, and is particularly applicable to natives in the UK. The second study gives hope that there may soon be a test or series of tests that will help predict those at an increased risk of suffering from pasture associated laminitis in the future thereby reducing the number of animals affected by this debilitating condition. In the meantime until we fully understand the condition it is sensible to manage all the risk factors we currently know about, in particular keeping your horse at a healthy weight."